Massachusetts state Sen. Mark C.W. Montigny in a Senate committee hearing, expressed concern over reports that agreements already had been made between the state and Boston biotech companies in connection with Gov. Deval Patrick's $1 billion life sciences bill. The state Economic Development Secretary agreed with Montigny that the bill should benefit the life sciences industry in all regions of the state, not just in Boston.
Published in Brief: